Citations (25)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Larysa Strilchuk, Giuliano Tocci, Federica Fogacci & Arrigo F. G. Cicero. (2020) An overview of rosuvastatin/ezetimibe association for the treatment of hypercholesterolemia and mixed dyslipidemia. Expert Opinion on Pharmacotherapy 21:5, pages 531-539.
Read now
Read now
Z. Zhu, S. Jiang, C. Li, J. Liu & M. Tao. (2020) Relationship between serum homocysteine and different menopausal stage. Climacteric 23:1, pages 59-64.
Read now
Read now
Articles from other publishers (23)
Mehrzad Mirshekari, Nooshin Shirzad, Mahboobeh Hemmatabadi & Soha Namazi. (2023) The approach of Iranian clinical pharmacists in the treatment of dyslipidemia based on international guidelines. Journal of Cardiovascular and Thoracic Research 15:1, pages 30-36.
Crossref
Crossref
Wouter B van Dijk, Ewoud Schuit, Rieke van der Graaf, Rolf H H Groenwold, Sara Laurijssen, Barbara Casadei, Marco Roffi, Seye Abimbola, Martine C de Vries & Diederick E Grobbee. (2023) Applicability of European Society of Cardiology guidelines according to gross national income. European Heart Journal 44:7, pages 598-607.
Crossref
Crossref
Abdullah Nadeem, Rabeea Tariq & Areeba Basaria. (2023) Inclisiran: a novel drug for the treatment of dyslipidemia. Annals of Medicine & Surgery 85:1, pages 59-60.
Crossref
Crossref
Lian Peng, Leilei Liu, Nana Ma, Fan Yang, Chan Nie, Tingting Yang, Qibing Zeng, Ziyun Wang, Degan Xu, Lu Ma, Yuyan Xu & Feng Hong. (2022) The dose-response relationship of serum uric acid with Dyslipidaemia and its components: a cross-sectional study of a Chinese multi-ethnic cohort. Lipids in Health and Disease 21:1.
Crossref
Crossref
Mohammed Khoshnaw & Kawa Dizaye. (2022) Beneficial effects of vitamin D in the management of untreated hyperlipidemia in diabetic patients in Erbil, Iraq. Pharmacia 69:3, pages 847-853.
Crossref
Crossref
Sanjana Misra, Tanica Lyngdoh & Rubina Mulchandani. (2022) Guidelines for dyslipidemia management in India: A review of the current scenario and gaps in research. Indian Heart Journal 74:5, pages 341-350.
Crossref
Crossref
Maria Llaine J. Callanta & Ourlad Alzeus G. Tantengco. (2022) Dyslipidemia research landscape and socioeconomic facilitators of scientific productivity in Southeast Asia. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 16:8, pages 102583.
Crossref
Crossref
Nuntakorn Thongtang, Renan Sukmawan, Elmer Jasper B. Llanes & Zhen-Vin Lee. (2022) Dyslipidemia management for primary prevention of cardiovascular events: Best in-clinic practices. Preventive Medicine Reports 27, pages 101819.
Crossref
Crossref
Rahanuma Raihanu Kathak, Abu Hasan Sumon, Noyan Hossain Molla, Mahmudul Hasan, Rakib Miah, Humaira Rashid Tuba, Ahsan Habib & Nurshad Ali. (2022) The association between elevated lipid profile and liver enzymes: a study on Bangladeshi adults. Scientific Reports 12:1.
Crossref
Crossref
Nasreen Alsayed, Wael Almahmeed, Fahad Alnouri, Khalid Al-Waili, Hani Sabbour, Kadhim Sulaiman, Mohammad Zubaid, Kausik K. Ray & Khalid Al-Rasadi. (2022) Consensus clinical recommendations for the management of plasma lipid disorders in the Middle East: 2021 update. Atherosclerosis 343, pages 28-50.
Crossref
Crossref
Ashraf Reda, Hany Ragy, Kanwal Saeed & Mohammed Ashraf Alhussaini. (2021) A semi-systematic review on hypertension and dyslipidemia care in Egypt—highlighting evidence gaps and recommendations for better patient outcomes. Journal of the Egyptian Public Health Association 96:1.
Crossref
Crossref
Xiaoyu Hou, Yunpeng Guan, Yong Tang, An Song, Jiajun Zhao, Luping Ren, Shuchun Chen, Limin Wei, Huijuan Ma & Guangyao Song. (2021) A correlation study of the relationships between nonalcoholic fatty liver disease and serum triglyceride concentration after an oral fat tolerance test. Lipids in Health and Disease 20:1.
Crossref
Crossref
Zhen-Vin Lee, Elmer Jasper Llanes, Renan Sukmawan, Nuntakorn Thongtang, Huynh Quang Tri Ho & Philip Barter. (2021) Prevalence of plasma lipid disorders with an emphasis on LDL cholesterol in selected countries in the Asia-Pacific region. Lipids in Health and Disease 20:1.
Crossref
Crossref
R. Nirwan & D. Singh. (2021) Distribution of Lipids and Prevalence of Dyslipidemia among Indian Expatriates in Qatar. Journal of Lipids 2021, pages 1-9.
Crossref
Crossref
Abdul Basit, Sobia Sabir, Musarrat Riaz, Asher Fawwad, Mujeeb Ur Rehman Abro, Khawaja Ishfaq Ahmed, Khurshid Ahmed, Ahmed Bilal, Anam Butt, Bikha Ram Devrajani, Ijaz Hayder, Yasir Humayun, Rabia Irshad, Riasat Ali Khan, Asima Khan, Aamir Akram Khowaja, Raheela Khowaja, Qazi Masroor, Maqsood Mehmood, Hassan Moin, Nida Mustafa, Wasif Noor, Huma Qureshi, Ibrar Rafique, Tahir Rasool, Rubina Sabir, M. Arif N. Saqib, Pir Alam Said, Abrar Shaikh, AS Shera, Bilal Tahir, Bilal Bin Younus, Salma Tanveer & Jamal Zafar. (2020) NDSP 05: Prevalence and pattern of dyslipidemia in urban and rural areas of Pakistan; a sub analysis from second National Diabetes Survey of Pakistan (NDSP) 2016–2017. Journal of Diabetes & Metabolic Disorders 19:2, pages 1215-1225.
Crossref
Crossref
Hwa-Yong Lee & In-Sun Hong. (2020) Metabolic Regulation and Related Molecular Mechanisms in Various Stem Cell Functions. Current Stem Cell Research & Therapy 15:6, pages 531-546.
Crossref
Crossref
Ashraf Reda, Wael Almahmeed, Idit Dobrecky-Mery, Po-Hsun Huang, Ursulo Juarez-Herrera, Naresh Ranjith, Tobias Sayre & Miguel Urina-Triana. (2020) A Narrative Review and Expert Panel Recommendations on Dyslipidaemia Management After Acute Coronary Syndrome in Countries Outside Western Europe and North America. Advances in Therapy 37:5, pages 1754-1777.
Crossref
Crossref
Shu-Lin Chang, Kuan-Jung Lee, Oswald Ndi Nfor, Pei-Hsin Chen, Wen-Yu Lu, Chien Chang Ho, Chia-Chi Lung, Ming-Chih Chou & Yung-Po Liaw. (2020) Vegetarian Diets along with Regular Exercise: Impact on High-Density Lipoprotein Cholesterol Levels among Taiwanese Adults. Medicina 56:2, pages 74.
Crossref
Crossref
Anwar Santoso, Teuku Heriansyah & Mohammad S. Rohman. (2020) Phospholipase A2 is an Inflammatory Predictor in Cardiovascular Diseases: Is there any Spacious Room to Prove the Causation?. Current Cardiology Reviews 16:1, pages 3-10.
Crossref
Crossref
Qinqin Wang & Chun Liang. (2020) Role of Lipid-Lowering Therapy in Low-Density Lipoprotein Cholesterol Goal Attainment: Focus on Patients With Acute Coronary Syndrome. Journal of Cardiovascular Pharmacology 76:6, pages 658-670.
Crossref
Crossref
Yaling Han, Jiyan Chen, Vijay Kumar Chopra, Shuyang Zhang, Guohai Su, Changsheng Ma, Zhouqing Huang, Yingyan Ma, Zhuhua Yao, Zuyi Yuan, Qiang Zhao, Srun Kuanprasert, Marie T. Baccara-Dinet, Garen Manvelian, Jianyong Li & Rui Chen. (2020) ODYSSEY EAST: Alirocumab efficacy and safety vs ezetimibe in high cardiovascular risk patients with hypercholesterolemia and on maximally tolerated statin in China, India, and Thailand. Journal of Clinical Lipidology 14:1, pages 98-108.e8.
Crossref
Crossref
Ning Song, Fen Liu, Min Han, Qiang Zhao, Qian Zhao, Hui Zhai, Xiang-Mei Li, Guo-Li Du, Xiao-Mei Li & Yi-Ning Yang. (2019) Prevalence of overweight and obesity and associated risk factors among adult residents of northwest China: a cross-sectional study. BMJ Open 9:9, pages e028131.
Crossref
Crossref
Hyunjung Lim, Jieun Kim & Do-Yeon Kim. (2019) Nutritional Therapy for Asian Patients at Risk for Atherosclerotic Cardiovascular Disease. Journal of Lipid and Atherosclerosis 8:2, pages 192.
Crossref
Crossref